About Fuso Pharmaceutical Industries, Ltd. Company History

The history of Fuso Pharmaceutical Industries, Ltd. from its founding.
Thoughts of Fuso Pharmaceutical Industries
2019（Reiwa 1）
Product
  • Lanthanum Carbonate OD Tablets "FUSO"
  • HiGROW OIL Heavy
2020（Reiwa 2）
Company
BAFSEO Tablets for the treatment of renal anemia

Signed a co-promotion agreement with Mitsubishi Tanabe Pharma Corporation for BAFSEO Tablets, a hypoxia-inducible factor–prolyl hydroxylase inhibitor for treatment of renal anemia in dialysis.

Launched Kindaly 5 Series

Launched "Kindaly 5 Series" dialysate for hemodialysis.

Product
  • Kindaly AF-5 (6L,9L)
  • Kindaly AF-5P
  • Kindaly 5E
  • Tadalafil Tablets ZA "FUSO"
  • Dutasteride Capsules AV "FUSO"
  • HiGROW HFF
2021（Reiwa 3）
Company
Succeeded in manufacturing and marketing approval of Miotecter and four infusion products

Succeeded in manufacturing and marketing approval of Miotecter, GLUACETO 35 Injection, Klinisalz, HARTMANN-G3, and Hartmann’s D SOLUTION KOBAYASHI from KYOWA CritiCare Pharma Co., Ltd. (currently neo CritiCare Pharma Co., Ltd.).

Product
  • Miotecter
  • GLUACETO 35 Injection
  • Klinisalz
  • HARTMANN-G3
  • Hartmann’s D SOLUTION KOBAYASHI
2022（Reiwa 4）
Company
Moved to the Prime Market of the Tokyo Stock Exchange

Moved ahead to be in the First Section of the Tokyo Stock Exchange, the Prime Market.

Product
  • Levocarnitine FF Syringes "FUSO"
2023（Reiwa 5）
Company
Opened the Maishima Distribution Center

The Maishima Distribution Center was opened at the Maishima RDC of Koyoshoji Corporation.

Product
  • DOPACOL TABLETS L250
  • Argatroban HI Injection 10mg / 2mg ”FUSO”
About Fuso Pharmaceutical Industries, Ltd.
Company Information TOP